首页 | 本学科首页   官方微博 | 高级检索  
     

新辅助放化疗联合盆腔脏器切除术治疗45例复发性直肠癌
引用本文:何桦波,武伟. 新辅助放化疗联合盆腔脏器切除术治疗45例复发性直肠癌[J]. 中国中西医结合外科杂志, 2011, 17(5): 455-458. DOI: 10.3969/j.issn.1007-6948.2011.05.002
作者姓名:何桦波  武伟
作者单位:杭州师范大学附属医院普外科,杭州,310015
摘    要:目的:探讨新辅助放化疗联合盆腔脏器切除术在复发性直肠癌治疗中的价值。方法:对45例复发直肠癌患者采用新辅助放化疗方案治疗常规分割放疗,治疗结束后4~6周进行盆腔脏器切除手术。结果:经新辅助放化疗后,病理完全缓解9例,肿瘤平均缩小38.4%,68.9%的病例T期下降。全组R0切除率为82.2%,手术并发症为20.0%,3年生存率为80.0%,5年生存率为44.4%。结论:新辅助放化疗联合盆腔脏器切除术是治疗复发性直肠癌的有效方法,通过降低肿瘤病期,提高手术切除率,从而提高患者生存率。

关 键 词:复发性直肠癌  新辅助治疗  盆腔脏器切除术

Clinical Study on Efficiency with Neoadjuvant Chemoradiotherapy in Combination with Pelvic Exenteration on Locally Recurrent Rectal Cancer:A Report of 45 Cases
He Huabo,Wu Wei. Clinical Study on Efficiency with Neoadjuvant Chemoradiotherapy in Combination with Pelvic Exenteration on Locally Recurrent Rectal Cancer:A Report of 45 Cases[J]. Chinese Journal of Surgery of Integrated Traditional and Western Medicine, 2011, 17(5): 455-458. DOI: 10.3969/j.issn.1007-6948.2011.05.002
Authors:He Huabo  Wu Wei
Affiliation:He Huabo,Wu Wei.
Abstract:Objective To explore the efficiency with neoadjuvant chemoradiotherapy(NCR) in combination with pelvic exenteration on locally recurrent rectal cancer.Methods Fourty-five patients with locally recurrent rectal cancer were received a new regiment of combined preoperative chemotherapy with radiotherapy.Routine fraction of radiation was given with total dose 46Gy,2 Gy per fraction,five times a week.Patients received oxaliplation 130 mg/m2(infusion) on day 1,plus leucovorin 200 mg/m2 and 5-Fu 500 mg/m2 from day...
Keywords:recurrent rectal cancer  neoadjuvant chemoradiotherapy  pelvic exenteration  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号